The pharmaceutical industry strengthens its commitment to pediatric clinical research and already promotes nine out of ten trials in this field
Farmaindustria participates in Santiago de Compostela in the II National Meeting of the Spanish Network of Pediatric Clinical Trials Source: www.farmaindustria.es The research and development of new drugs specially adapted for pediatric patients has been carried out mostly by the pharmaceutical industry in recent years. Specifically, 88.7% of the clinical trials authorized since 2015 and […]
More hospitals aspire to become CAR-T centers
Source: IM Medical Publimas Digital s.l. The Ministry of Health and the Autonomous Communities have met to assess the suitability of new candidates to administer this type of therapy. During the Plenary of the Interterritorial Council of the National Health System held last May, the first phase of designation of the centers that opted for […]
New drugs in cardiovascular disease, a success story
The pharmaceutical industry currently has about 600 new treatments against developing cardiovascular pathologies This Sunday, September 29, World Heart Day is celebrated Source: www.farmaindustria.es Cardiovascular diseases are sadly at the forefront of mortality in the world, and especially in developed countries such as Spain, where these pathologies are responsible for 28.8% of deaths, compared to […]
The pharmaceutical industry develops in Spain almost 200 clinical trials on lung cancer
The European Week of this tumor has been celebrated, of which almost 30,000 new cases are diagnosed each year in Spain Despite being one of the cancers with the lowest survival, it has increased more than 20% in the last decade thanks to new treatments Source: www.farmaindustria.es The pharmaceutical industry has underway in Spain about […]
Pharmaceutical companies reaffirm their commitment to research and access to innovation in Spain
Predictability, adequate taxation and imagination in the search for solutions, within the framework of a constant dialogue with the Administration, keys to ensure the advancement of biomedical R&D in Spain Responsible for MSD, Roche, Amgen and Rovi Laboratories participated in a round table at the XIX Meeting of the Spanish Pharmaceutical Industry in Santander […]
A global and long-term analysis of the medication is essential to consider all its health, economic and social benefits
Impact on patient health, health system management and economic growth, among the most relevant effects The director of the Department of Pharmaceutical Studies, Pedro Luis Sánchez, analyzes in ‘Spanish Economy Papers’ the scientific evidence Source: www.farmaindustria.es To consider the medicine in a global way, analyzing all its benefits and costs, and doing so over a […]
Each year 15,000 patients participate in clinical trials promoted by the pharmaceutical industry in Spain
Each year 15,000 patients participate in clinical trials promoted by the pharmaceutical industry in Spain Source: www.farmaindustria.es Spain has become one of the reference countries in clinical research, to the point that each year almost 15,000 patients participate in clinical trials (the phase of the development of new drugs in which the safety and efficacy […]
“Spanish society should know that participating in a clinical trial is something beneficial”
Farmaindustria participates in the program ‘Es la Tarde de Dieter’, by EsRadio, in a debate on clinical research in Spain Source: www.farmaindustria.es Clinical trials, which are the studies that determine the safety and efficacy of a new drug for authorization, have great value for all agents in the healthcare chain: for patients, who thanks to […]
Pharmaceutical companies, managers, healthcare professionals and researchers seek to strengthen the excellence of clinical trials in Spain
Farmaindustria brings together in Madrid more than 120 experts to continue advancing in an area in which our country is already an international benchmark Source: www.farmaindustria.es What are the criteria that the centers must meet to host clinical trials; how to improve its management or how to facilitate patient participation. Some of the questions that […]
The pharmaceutical industry facilitates the participation of more than 150,000 patients in clinical trials in the last 12 years
More than half of the clinical research with medicines is done in the early stages, the most complex Strengthen the participation of patients in all stages of research, one of the challenges to continue driving trials in Spain Source: www.farmaindustria.es More than 150,000 patients have participated in clinical trials promoted in Spain by the innovative […]
ES
EN